Ron Zwanziger has just started his third company, just sold the last $ 1.3 billion Johnson & Johnson. Under the deal with J & J, certain assets were transferred to the new company, Inverness Medical Innovations, which, at its inception, it was $ 24 million in the half year sales of $ 40 million on its balance sheet and operations around the world. As Zwanziger and his team are going to turn these disparate assets of the company for $ 7 billion in the next seven years? "Hide
by Daniel J. Isenberg Source: Harvard Business School 11 pages. Publication date: April 10, 2006. Prod. #: 806177-PDF-ENG
Related Case Solutions & Analyses:
Colby General Hospital (D): Performance Improvement System Stalls Out
Colby General Hospital (A)
Becton Dickinson: Ethics and Business Practices (A)
Jan Eriksson at Novartis Indonesia: Turmoil in the Indonesian Pharmaceutical Industry
Office Design Partners (Thailand) Ltd.
AIC Netbooks: Optimizing Product Assembly
LEGO
Research In Motion: The Mobile OS Platform War
The Project Life Cycle: Selection
Operations Management: An Introduction to Process Analysis
